Unknown

Dataset Information

0

Deferasirox for managing iron overload in people with thalassaemia.


ABSTRACT:

SUBMITTER: Bollig C 

PROVIDER: S-EPMC6483623 | biostudies-literature | 2017 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Deferasirox for managing iron overload in people with thalassaemia.

Bollig Claudia C   Schell Lisa K LK   Rücker Gerta G   Allert Roman R   Motschall Edith E   Niemeyer Charlotte M CM   Bassler Dirk D   Meerpohl Joerg J JJ  

The Cochrane database of systematic reviews 20170815


<h4>Background</h4>Thalassaemia is a hereditary anaemia due to ineffective erythropoiesis. In particular, people with thalassaemia major develop secondary iron overload resulting from regular red blood cell transfusions. Iron chelation therapy is needed to prevent long-term complications.Both deferoxamine and deferiprone are effective; however, a review of the effectiveness and safety of the newer oral chelator deferasirox in people with thalassaemia is needed.<h4>Objectives</h4>To assess the ef  ...[more]